BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...participation from new investors Solasta Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington...
BioCentury | Jan 6, 2021
Product Development

Propelled by Ionis deal, Aro raises $88M series A to advance targeted oligo pipeline

...an $88 million series A round Tuesday led by Northpond Ventures and Cowen Healthcare Investments. HealthCap...
BioCentury | Nov 19, 2020
Finance

VCs back Celleron spinout with €37M to develop former Roche asset for rare joint disorder

...to treat tenosynovial giant cell tumors (TGCT), a rare non-cancerous, non-metastatic disorder that affects the joints.HealthCap...
...in that context.Celleron raised an undisclosed amount of funding in 2017 from a South Korean syndicate.HealthCap's...
BioCentury | Oct 21, 2020
Deals

Oct. 21 Quick Takes: Clear path for BMS in MyoKardia deal; plus WuXi Biologics rises, Purdue settles, Actemra, Cara-Vifor and more

...affiliate and including existing investors Deerfield Management, HealthCap...
BioCentury | Oct 12, 2020
Finance

Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting

...just in AML but also other hematological malignancies,” Rogan said.Fountain led the round alongside co-leader HealthCap...
...Novartis, and Patel held a board seat.In addition to Rogan and Patel, Priothera’s board includes HealthCap’s Mårten...
BioCentury | Jul 10, 2020
Finance

With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund

...managing partners. But VCs who are especially focused on Scandinavia are few. Christgau said Sweden’s HealthCap...
...Magnus Persson has held partner or executive roles at Karolinska Development, The Column Group and HealthCap...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...mAb targeting IGF1R that is linked to the α-emitting cytotoxic isotope actinium-225. Fusion’s shareholders include HealthCap...
BioCentury | Feb 20, 2020
Finance

With $88M series B, Spruce seeks short path to approval in rare endocrine disorder

...were existing investors Novo Holdings A/S and RiverVest Venture Partners, as well as first-time backers HealthCap...
BioCentury | Sep 10, 2019
Financial News

Sept. 10 Financial Quick Takes: Qiming backs Insilico's B round; plus 10x Genomics, Aprea, Platelet, SGI-DNA, Dermavant, Karuna Labs

...with a 10% or greater stake in the company are KDev Group, Versant, 5AM Ventures, HealthCap...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Emerge Preclin Neurology 2016 Camel-IDS N.V. Brussels, Belgium $41.7 V-Bio Ventures , Gimv N.V. , HealthCap...
Items per page:
1 - 10 of 242
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...participation from new investors Solasta Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington...
BioCentury | Jan 6, 2021
Product Development

Propelled by Ionis deal, Aro raises $88M series A to advance targeted oligo pipeline

...an $88 million series A round Tuesday led by Northpond Ventures and Cowen Healthcare Investments. HealthCap...
BioCentury | Nov 19, 2020
Finance

VCs back Celleron spinout with €37M to develop former Roche asset for rare joint disorder

...to treat tenosynovial giant cell tumors (TGCT), a rare non-cancerous, non-metastatic disorder that affects the joints.HealthCap...
...in that context.Celleron raised an undisclosed amount of funding in 2017 from a South Korean syndicate.HealthCap's...
BioCentury | Oct 21, 2020
Deals

Oct. 21 Quick Takes: Clear path for BMS in MyoKardia deal; plus WuXi Biologics rises, Purdue settles, Actemra, Cara-Vifor and more

...affiliate and including existing investors Deerfield Management, HealthCap...
BioCentury | Oct 12, 2020
Finance

Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting

...just in AML but also other hematological malignancies,” Rogan said.Fountain led the round alongside co-leader HealthCap...
...Novartis, and Patel held a board seat.In addition to Rogan and Patel, Priothera’s board includes HealthCap’s Mårten...
BioCentury | Jul 10, 2020
Finance

With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund

...managing partners. But VCs who are especially focused on Scandinavia are few. Christgau said Sweden’s HealthCap...
...Magnus Persson has held partner or executive roles at Karolinska Development, The Column Group and HealthCap...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...mAb targeting IGF1R that is linked to the α-emitting cytotoxic isotope actinium-225. Fusion’s shareholders include HealthCap...
BioCentury | Feb 20, 2020
Finance

With $88M series B, Spruce seeks short path to approval in rare endocrine disorder

...were existing investors Novo Holdings A/S and RiverVest Venture Partners, as well as first-time backers HealthCap...
BioCentury | Sep 10, 2019
Financial News

Sept. 10 Financial Quick Takes: Qiming backs Insilico's B round; plus 10x Genomics, Aprea, Platelet, SGI-DNA, Dermavant, Karuna Labs

...with a 10% or greater stake in the company are KDev Group, Versant, 5AM Ventures, HealthCap...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Emerge Preclin Neurology 2016 Camel-IDS N.V. Brussels, Belgium $41.7 V-Bio Ventures , Gimv N.V. , HealthCap...
Items per page:
1 - 10 of 242